Evidence map›Paper›PMID 38156047›Full record

ArticleOpen forum infectious diseases2023

A Clinicopathological Categorization System for Clinical Research in Coccidioidomycosis.

Paul Krogstad, George R Thompson, Arash Heidari, Rasha Kuran, Alexis V Stephens, Manish J Butte, Royce Johnson

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Rising burden of severe pediatric coccidioidomycosis: a 25-year single-center study.Journal of the Pediatric Infectious Diseases Society · 2026
    Observational
  5. Exhausted T cell phenotypes in disseminated coccidioidomycosis.medRxiv : the preprint server for health sciences · 2026
    Article
  6. Type-2 immune skewing in patients with disseminated coccidioidomycosis.medRxiv : the preprint server for health sciences · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. The Host Response to Coccidioidomycosis.Journal of fungi (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paul KrogstadDepartment of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.ORCID https://orcid.org/0000-0001-6191-6213
George R ThompsonDivision of Infectious Diseases, UC Davis School of Medicine, Sacramento California, USA.ORCID https://orcid.org/0000-0001-8518-5750
Arash HeidariDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.ORCID https://orcid.org/0000-0003-1091-348X
Rasha KuranDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Alexis V StephensInstitute of Precision Health, University of California, Los Angeles, California, USA.
Manish J ButteDepartment of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Royce JohnsonDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Funding

Innate immune mechanisms of the host response to CoccidioidesU19AI166059 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Royce Harwood Johnson · 2022 to 2026
$10.0M
T-cell Dysfunction as the basis of Disseminated CoccidioidomycosisR21AI149654 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BUTTE, MANISH J · 2021 to 2022
$421k
NIAID NIH HHS R21 AI149654NIAID NIH HHS U19 AI166059
6 · The paper itself

Abstract

A wide array of clinical manifestations follow infection with

Indexed as

coccidioidomycosisdisseminationmeningitispathologyvalley fever

Identifiers

PMID38156047
PMCPMC10753911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.